- Investor Relations > Press Releases
Stock Quote

SEC Filings

Press Releases

2009/2010 News | 2008 News | 2007 News | 2006 News | 2005 News | 2004 News | 2003 News

February 5, 2010
Health Discovery Corporation Partners with Major New York City Pancreatic Cancer Center to Develop a New Molecular Diagnostic Test for the Early Detection of Pancreatic Cancer

February 3, 2010
Vermillion Pays Health Discovery Corporation Final Patent Infringement Settlement Payment

February 2, 2010
Health Discovery Corporation's Test May Help Curb the Second-Leading Cause of Cancer Death.

November 30, 2009
Health Discovery Corporation Appoints Tom Gallagher, former Wall Street Attorney & a Vice President at Goldman, Sachs & Co., to Head the Company's Global Intellectual Property Strategies

November 4, 2009
Health Discovery Corporation Offers an Intra-Quarterly Update, Commentary on the Value of Prostate Cancer Screening and Invites the American Cancer Society to Act Immediately

October 19, 2009
Health Discovery Corporation Announces Addtional Issued Patents and Notices of Allowances to Its Intellectual Property Portfolio

October 9, 2009
Health Discovery Corporation Hires The Dilenschneider Group, a New Yourk City IR/PR Firm

September 24, 2009
Health Discovery Corporation's Dr. Stephen Barnhill Tells Participants at London Conference That Biomarkers Patented by His Company Promise to Revolutionize the Field of Molecular Diagnostics

September 18, 2009
Former Deputy FDA Commissioner John Norris Appointed Chief Operating Officer at Health Discovery Corporation

July 14, 2009
Health Discovery Corporation Announces Publication of Peer Reviewed Scientific Paper Demonstrating the Clinical Validity of the Four-Gene Prostate Cancer Test Licensed to Abbott, Quest Diagnostics and Clarient

May 4, 2009
Health Discovery Corporation Names R. Scott Tobin as President and General Counsel

February 5, 2009
Health Discovery Corporation Licenses Biomarkers for Noninvasive Urine-Based Prostate Cancer Test to Quest Diagnostics

February 5, 2009
Health Discovery Corporation Licenses New Prostate Cancer Test to Abbott

January 13, 2009
Clarient Launches Gene Expression Test for Prostate Cancer

© 2010 Health Discovery Corporation Stock Symbol: HDVY.OB 1.912.443.1987